South Korea
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 430.77 M
|
Dec. 31, 2023 | USD 698.37 | 1.93% |
|
South Korea |
|
2 |
USD 191.50 M
|
Dec. 31, 2023 | USD 64.45 | 0.31% |
|
South Korea |
|
3 |
USD 140.87 M
|
Dec. 31, 2023 | USD 125.83 | 1.12% |
|
South Korea |
|
4 |
USD 132.71 M
|
Dec. 31, 2023 | USD 177.66 | 0.74% |
|
South Korea |
|
5 |
USD 89.64 M
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
6 |
USD 48.42 M
|
Dec. 31, 2023 | USD 17.02 | -2.20% |
|
South Korea |
|
7 |
USD 39.74 M
|
Dec. 31, 2023 | USD 171.86 | 2.57% |
|
South Korea |
|
8 |
USD 35.68 M
|
Dec. 31, 2023 | USD 16.03 | -1.15% |
|
South Korea |
|
9 |
USD 23.90 M
|
Dec. 31, 2023 | USD 10.03 | -2.25% |
|
South Korea |
|
10 |
USD 23.84 M
|
Dec. 31, 2023 | USD 16.27 | 0.32% |
|
South Korea |
|
11 |
USD 22.51 M
|
Dec. 31, 2023 | USD 7.40 | 0.83% |
|
South Korea |
|
12 |
USD 22.02 M
|
Dec. 31, 2023 | USD 11.69 | 2.23% |
|
South Korea |
|
13 |
USD 20.75 M
|
Dec. 31, 2023 | USD 2.05 | 0.07% |
|
South Korea |
|
14 |
USD 20.34 M
|
Dec. 31, 2023 | USD 19.95 | 0.05% |
|
South Korea |
|
15 |
USD 16.78 M
|
Dec. 31, 2023 | USD 26.12 | -1.82% |
|
South Korea |
|
16 |
USD 14.56 M
|
Dec. 31, 2023 | USD 26.36 | -7.63% |
|
South Korea |
|
17 |
USD 14.50 M
|
Dec. 31, 2023 | USD 7.02 | 1.13% |
|
South Korea |
|
18 |
USD 10.67 M
|
Dec. 31, 2023 | USD 89.82 | -0.84% |
|
South Korea |
|
19 |
USD 7.53 M
|
Dec. 31, 2023 | USD 8.46 | 0.09% |
|
South Korea |
|
20 |
USD 6.32 M
|
Dec. 31, 2023 | USD 3.25 | 1.59% |
|
South Korea |
|
21 |
USD 6.22 M
|
Dec. 31, 2023 | USD 14.32 | 2.94% |
|
South Korea |
|
22 |
USD 5.28 M
|
Dec. 31, 2023 | USD 8.31 | 1.99% |
|
South Korea |
|
23 |
USD 4.45 M
|
Dec. 31, 2023 | USD 5.79 | -4.44% |
|
South Korea |
|
24 |
USD 3.89 M
|
Dec. 31, 2023 | USD 32.09 | 0.74% |
|
South Korea |
|
25 |
USD 2.96 M
|
Dec. 31, 2023 | USD 13.23 | 1.89% |
|
South Korea |
|
26 |
USD 2.36 M
|
Dec. 31, 2023 | USD 1.83 | 0.74% |
|
South Korea |
|
27 |
USD 2.17 M
|
Dec. 31, 2023 | USD 4.37 | 0.43% |
|
South Korea |
|
28 |
USD 2.09 M
|
March 31, 2024 | USD 1.22 | 1.14% |
|
South Korea |
|
29 |
USD 1.94 M
|
Dec. 31, 2023 | USD 3.68 | 0.18% |
|
South Korea |
|
30 |
USD 1.88 M
|
Dec. 31, 2023 | USD 10.59 | -0.10% |
|
South Korea |
|
31 |
USD 1.65 M
|
Dec. 31, 2023 | USD 3.09 | 1.75% |
|
South Korea |
|
32 |
USD 1.27 M
|
Dec. 31, 2023 | USD 9.82 | 0.39% |
|
South Korea |
|
33 |
USD -251.66 K
|
Dec. 31, 2023 | USD 5.07 | 0.47% |
|
South Korea |
|
34 |
USD -415.60 K
|
Dec. 31, 2023 | USD 0.92 | 1.72% |
|
South Korea |
|
35 |
USD -475.20 K
|
Dec. 31, 2023 | USD 11.51 | 2.62% |
|
South Korea |
|
36 |
USD -633.81 K
|
Dec. 31, 2023 | USD 68.20 | 0.14% |
|
South Korea |
|
37 |
USD -1.04 M
|
Dec. 31, 2023 | USD 12.88 | 0.37% |
|
South Korea |
|
38 |
USD -1.68 M
|
Dec. 31, 2023 | USD 13.36 | 2.04% |
|
South Korea |
|
39 |
USD -3.60 M
|
Dec. 31, 2023 | USD 3.34 | 1.67% |
|
South Korea |
|
40 |
USD -3.90 M
|
Dec. 31, 2023 | USD 38.12 | 0.02% |
|
South Korea |
|
41 |
USD -4.01 M
|
Dec. 31, 2023 | USD 2.96 | 1.21% |
|
South Korea |
|
42 |
USD -4.67 M
|
Dec. 31, 2023 | USD 4.09 | 4.76% |
|
South Korea |
|
43 |
USD -4.72 M
|
Dec. 31, 2023 | USD 12.09 | 2.36% |
|
South Korea |
|
44 |
USD -5.01 M
|
Dec. 31, 2023 | USD 1.27 | 0.36% |
|
South Korea |
|
45 |
USD -5.07 M
|
Dec. 31, 2023 | USD 9.81 | 0.60% |
|
South Korea |
|
46 |
USD -6.28 M
|
Dec. 31, 2023 | USD 1.26 | 0.79% |
|
South Korea |
|
47 |
USD -6.28 M
|
Dec. 31, 2023 | USD 0.38 | 0.74% |
|
South Korea |
|
48 |
USD -6.37 M
|
Dec. 31, 2023 | USD 8.29 | 0.57% |
|
South Korea |
|
49 |
USD -6.50 M
|
Dec. 31, 2023 | USD 0.95 | -1.80% |
|
South Korea |
|
50 |
USD -9.51 M
|
Dec. 31, 2023 | USD 11.90 | 0.22% |
|
South Korea |
The Health Care company in South Korea with the highest Free Cash Flow is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 430.77 M.
The Health Care company in South Korea with the lowest Free Cash Flow is SD BioSensor, Inc (KSE: 137310.KS) at USD -297.22 M.
The top 10 Health Care companies in South Korea by Free Cash Flow are Samsung Biologics Co.,Ltd., Chong Kun Dang Pharmaceutical Corp., Celltrion, Inc., Hanmi Pharm. Co., Ltd., Osang Healthcare Co.,Ltd, Seegene, Inc., PharmaResearch Co., Ltd., JW Pharmaceutical Corporation, Daewon Pharmaceutical Co., Ltd. and InBody Co.,Ltd.
The bottom 10 Health Care companies in South Korea by Free Cash Flow are SD BioSensor, Inc, Green Cross Holdings Corporation, Green Cross Corporation, SK Biopharmaceuticals Co., Ltd., Humasis Co. Ltd., Ildong Holdings Co., Ltd., Chabiotech Co.,Ltd., Aprogen pharmaceuticals,Inc., Yuhan Corporation and CrystalGenomics, Inc..